Physician profile
William Pakan
NPI 1780776070
$2,107.26
in general payments reported to CMS, 2019-2025
12 companies · $22.04 in 2025
The $22.04 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,635 · 2020: $67.42 · 2021: $154 · 2022: $54.53 · 2023: $88.70 · 2024: $84.97 · 2025: $22.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,350.81 | 2019 | |
| Stryker Corporation | $230.17 | 2019-2023 | Inspace, Allograft, Mako |
| Depuy Synthes Sales INC. | $168.29 | 2019-2024 | Truespan Orthocord, Dynacord, Na |
| Rock Medical Orthopedics, INC. | $123.54 | 2019 | |
| Smith+Nephew, INC. | $83.26 | 2022-2024 | |
| Bioventus LLC | $41.56 | 2024-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Fidia Pharma USA INC. | $24.15 | 2019 | |
| Vericel Corporation | $23.50 | 2020 | |
| Pacira Therapeutics, INC. | $21.25 | 2021 | |
| Arthrosurface Incorporated | $14.69 | 2019 | |
| Theragen, INC. | $13.90 | 2023 | Kneehab Xp |
| Anika Therapeutics, INC. | $12.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Pakan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.